Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The BBVA Foundation awards its 2007 Biomedicine Chairs

17.04.2008
The BBVA Foundation has decided its 2007 call for six Biomedicine Chairs, enabling the attachment of leading international specialists to Spanish groups of excellence working at basic and clinical research centers. The Chairs are funded with a combined amount of 1.2 million euros.

The aim of these Chairs is to facilitate knowledge transfer and strengthen cooperative ties between world-class teams and centers in Spain and international researchers who have made particularly significant contributions in their specialist fields. Further ahead, it is hoped they will contribute to improving the quality of healthcare available to citizens.

The selection of the Chairs, with a duration of between six months and a maximum of one year, was entrusted to an independent review panel. Three of the Biomedicine Chairs are awarded for basic research and another three for clinical research, each one financed with up to 200,000 euros.

BASIC BIOMEDICAL RESEARCH
In basic research, the BBVA Foundation Chair will facilitate the incorporation of Tamas Horvath, Professor of Comparative Medicine and Neurobiology at Yale University (United States) to the team led by Luis Miguel García Segura at the Instituto Cajal- CSIC (Madrid). The focus of their work will be on understanding the cellular contributions of various hormones to perinatal stress-induced alterations in brain functions.

The second basic research Chair goes to Hari Reddi, Lawrence J. Ellison Chair in Musculoskeletal Molecular Biology at the University of California, Davis (United States). Dr. Reddi will work with José Becerra’s team at the University of Malaga on a project dealing with the regeneration of damaged articular cartilage.

Anthony McNaughton, Sheild Professor and Head of the Department of Pharmacology at the University of Cambridge (United Kingdom) will join Carlos Belmonte’s team at the Instituto de Neurociencias de Alicante (University Miguel Hernández-CSIC). The aim of this research collaboration will be to elucidate how the temperature threshold of cold-sensitive ion channels is modulated at the molecular level,

CLINICAL BIOMEDICAL RESEARCH
The first Chair for clinical biomedical research has been awarded to Guadalupe García-Tsao, Professor of Medicine at Yale University (United States). She will work alongside Jaime Bosch and his team at the Hospital Clínic i Provincial-CIBERehd (Barcelona), exploring the non-invasive assessment of portal hypertension and its response to portal pressure-reducing pharmacological therapy.

Evan Balaban, Associate Professor on the Behavioral Neurosciences Program at McGill University (Canada), will join the team led by Manuel Desco at the Hospital General Universitario Gregorio Marañón (Madrid). Their shared research will focus on neuroimaging at the dawn of integrative brain function.

The third clinical research Chair goes to Richard Stanley Cooper, Professor of Medicine and Head of the Department of Preventive Medicine and Epidemiology at Loyola University (United States). Cooper will work with Josep Redón’s group at Hospital Clínico de Valencia on the study of genetics and molecular medicine in cardiovascular risk.

The review panel for the 2007 BBVA Foundation Chairs in Biomedicine was formed by Jesús Ávila of the Severo Ochoa Molecular Biology Center (CSIC-UAM, Madrid); Flora de Pablo, from the Instituto de Salud Carlos III (Madrid); Antonio López Farré, from Hospital Clínico San Carlos (Madrid); José M. Mato of CIC bioGUNE (Bilbao); Ricardo Moreno, from Hospital de la Princesa (Madrid); Juan Rodés, from Hospital Clínic i Provincial (Barcelona); and José Manuel Zubeldia, from Hospital General Universitario Gregorio Marañón (Madrid).

Javier Fernández | alfa
Further information:
http://www.fbbva.es
http://w3.grupobbva.com/TLFU/tlfu/ing/comunica/notas/fichanota/index.jsp?codigo=360

More articles from Awards Funding:

nachricht Breakthrough Prize for Kim Nasmyth
04.12.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH

nachricht The key to chemical transformations
29.11.2017 | Schweizerischer Nationalfonds SNF

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>